Insulin pen design can lead to missed doses for people with disabilities, patient safety investigation body finds The Health Services Safety Investigations Body said that patients with disabilities “experience recurring issues” with insulin pen devices.…
Medicines regulator to outsource some drug assessment work to private firms The Medicines and Healthcare products Regulatory Agency said that three companies have been given contracts to provide assessments of clinical and non-clinical regulatory data.…
Communication of risks of psychiatric side effects with fluoroquinolone antibiotics to be reviewed following death A patient who had taken his own life began taking prescribed ofloxacin the day before his death after a previously prescribed first-line antibiotic had been ineffective.…
MHRA extends approval for gene-editing therapy to patients aged five years and over Casgevy will now be used to treat younger patients with sickle-cell disease or transfusion-dependent β-thalassemia.…
New medicines need workable pathways towards delivery, not just formulary approval Even after MHRA approval, a NICE recommendation and formulary inclusion, there is still a long way to go before patients can benefit from new medicines.…
Pharmacists told to contact patients following clopidogrel recall A class two recall notice said that pharmacy teams should immediately identify and contact all patients who have been dispensed with the affected batches of Xeal Pharma-manufactured clopidogrel oral suspension and oral solution.…
Regulator to use AI for earlier safety signals and overhaul patient information by 2030 In its five-year strategy, the Medicines and Healthcare products Regulatory Agency has also pledged to publish an AI medicines development plan in 2027 for the “safe and effective use of AI”.…
Pharmacies could stock antidepressant suicidal behaviour warnings Health minister James Frith said that patient information leaflets clarifying that suicidal behaviours may persist after treatment stops are expected to be available electronically from October 2026 and in paper copies within three to six months.…
Self-administered injections should be considered for reclassification, says OTC body PAGB calls for change to medication legislation so that injectable products could be reclassified to P medicines.…
Government accepts all 44 recommendations from regulation of AI in healthcare report The government said its acceptance commits the UK to develop a “world-leading agile approach to AI device regulation” that would support innovation while maintaining patient safety.…
